KI-Beratung Beta

Produktbild: Smart Organ-On-Chip Devices

Smart Organ-On-Chip Devices Dynamic Microfluidic Systems for Cell Culture

168,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.06.2025

Herausgeber

Tiago Albertini Balbino + weitere

Verlag

Elsevier Science & Technology

Seitenzahl

230

Maße (L/B/H)

23,6/18,8/1,3 cm

Gewicht

499 g

Sprache

Englisch

ISBN

978-0-443-13403-6

Beschreibung

Portrait

Tiago Albertini Balbino, PhD, is a professor at the Alberto Luiz Coimbra Institute for Graduate Studies and Research in Engineering (COPPE) at the Federal University of Rio de Janeiro (UFRJ), Brazil. He coordinates the Graduate Program in Nanotechnology Engineering, which is housed at Latin America's largest center for research and education in engineering. Professor Balbino is a chemical engineer with a PhD and master's in chemical engineering from the UNICAMP (São Paulo, Brazil). His doctoral research focused on developing microfluidic processes for creating nanostructured systems used in vaccines and other nanomedicines, a focus he expanded during his internship at the National Institute of Standards and Technology (NIST) in the United States, where he worked on microfabrication techniques for biomedical applications. He later pursued a postdoctoral fellowship at the Department of Mechanical Engineering at PUC-Rio, advancing his expertise in microfluidic chip design. Currently, his work centers on designing innovative microfluidic chips to address challenges in nanotechnology engineering. He is also actively involved in advancing organ-on-chip technologies, with applications in drug development, disease modeling, and tissue engineering. His work bridges engineering and biomedical science, contributing to cutting-edge research that aims to transform healthcare and train the next generation of scientists and engineers.T

Paulo Bartolo is Professor of Advanced Manufacturing at the School of Mechanical and Aerospace Engineering (MAE), Nanyang Technological University (NTU), Executive Director of the Singapore Centre for 3D Printing (SC3DP), and Programme Director of the National Additive Manufacturing Innovation Cluster (NAMIC) hub at NTU. He is Fellow of CIRP (International Academy for Production Engineering), Honorary/Visiting Professor at several Universities in China, Europe and North America and Advisor of several Funding Agencies and Research Institutes across the world.

He authored/co-authored more than 700 publications in journal papers, book chapters and conference proceedings, co-edited 23 books and holds 16 patents in the fields of additive manufacturing, biomanufacturing and tissue engineering. Throughout his career he received several awards and public recognitions including the Gold Medal of Merit of the Portuguese Communities from the Portuguese Government, Professor Honoris Causa from the Polytechnic University of Leiria, the Kobayahi Award for his contributions in the field of biomanufacturing, commendations and public recognitions from the Portuguese Government and the Polytechnic University of Leiria published in the Portuguese Government's Law Journal and the Medal of Merit from the city of Leiria among others. Paulo Bartolo is among the Top 2% Scientists Worldwide.

Ms. Letícia Charelli has a BSc and an MSc in Biotechnology with emphasis on biofabrication, 3D cell culture, and microfluidics. She is currently working with industry players to optimize protocols for regenerative medicine, drug development, and disease modeling. Letícia uses her extensive knowledge to translate the research data from the bench to the bedside as a functional product. Her expertise in microfluidics (e.g., organ-on-chip platforms) have resulted in several international articles, partnership with industries as well as lecturing for undergraduate, graduate, and professionals of several fields.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.06.2025

Herausgeber

Verlag

Elsevier Science & Technology

Seitenzahl

230

Maße (L/B/H)

23,6/18,8/1,3 cm

Gewicht

499 g

Sprache

Englisch

ISBN

978-0-443-13403-6

EU-Ansprechpartner

Elsevier B.V.
Radarweg 29
1043 NX Amsterdam
NL
productsafety@elsevier.com

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Ein neues Kapitel für Ihre Bücher

Ein neues Kapitel für Ihre Bücher

Schenken Sie Ihren alten Schätzen ein zweites Leben und erhalten Sie dafür eine Thalia Geschenkkarte.

Jetzt verkaufen
Jetzt verkaufen

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Smart Organ-On-Chip Devices
  • SECTION 1: MICROFLUIDICS AND ORGAN-ON-CHIP TECHNOLOGIES
    1. Organotypic On-Chip Models: Bridging the Gap Between Traditional In Vitro Culture and Animal Testing
    2. Microfabrication Processes for the Manufacturing of Smart Organ-on-Chip Devices
    3. Bioprinted Organ-on-a-Chip: A Strategy to Achieve Humanized In Vitro Models
    4. Disease Modeling and Developmental Biology Through Microfluidic Channels
    5. Artificial Intelligence-Assisted Organ-on-Chip Systems

    SECTION 2: STIMULI ACTIVE ORGANOTYPIC-ON-CHIP DEVICES
    6. Mechanically Active Organotypic-On-Chip Devices for Dynamic Cell Culture
    7. Sensors within Microfluidic Chips: Optofluidics to Explore In Vitro Organoid Behavior
    8. Photothermal and Magnetic Cell Stimuli Caused by Nanoparticles Inside Organ-on-Chip Platforms

    SECTION 3: MICROPHYSIOLOGICAL CASE STUDIES
    9. Brain-on-Chip Microplatforms for Precision Medicine, Disease Modelling, and Developmental Biology
    10. Dynamic Microphysiological Systems to Access Sickle Cell Disease - A Case Study for Disease Modeling
    11. Microtechnologies and Mathematical Modeling in Signaling Cascades Multiorgan Microphysiological Systems
    12. Mechanically Active Heart-on-a-Chip: Toward a Reliable Heart Beating Study Model
    13. Remaining Challenges: Are We Close to a Physiologically Representative In Vitro Model for Clinical Deployment?